Primary cardiac solitary fibrous tumors were reviewed. They are classified as pericardial tumors. Their incidences are very rare. Only 16 cases were reported in the literature. Basically, surgical treatments are performed. Their prognoses are generally good, although malignant cases are also reported.
Background: Anaplastic lymphoma kinase (ALK)–tyrosine kinase inhibitors (TKIs) have been approved for the therapy of locally advanced non-small cell lung cancer (NSCLC) caused by ALK rearrangement. However, its treatment after failure of initial ALK–TKI therapy remains controversial. Case presentation: A 47-year-old woman with a hemosputum was diagnosed with adenocarcinoma of the left lung (cT2bN3M0, stage IIIB). Gene mutation analysis indicated positive ALK translocation. Alectinib was selected as the first-line treatment. Although the treatment effect was determined as a partial response, the main tumor regrew. Alectinib was discontinued, and salvage surgery was performed without causing morbidity. The pathological diagnosis was pleomorphic carcinoma without lymph node metastasis (yp-T2bN0). After surgery, lorlatinib was administered as the second-line treatment for 8 months until the patient could not tolerate continuation. Computed tomography scan revealed no lung cancer recurrence 14 months after discontinuation. Conclusions: Our experience with this case suggests that salvage surgery after alectinib treatment followed by lorlatinib therapy may be effective for initially unresectable ALK-positive NSCLC.
Introduction: Primary thymic adenocarcinoma is a notably rare neoplasm. Here, we described a case of non-papillary thymic adenocarcinoma that was comparable to adenocarcinoma not otherwise specified (NOS) according to the recent WHO classification. Case Report: A 69-year-old woman presented to our hospital with an anterior mediastinal tumor. Thymothymectomy was performed. Histological examination revealed dense proliferation of irregular tubular and partially solid atypical cells with fibrous stroma. Based on pathological and immunohistochemical findings, and the absence of primary tumors in other sites, a diagnosis of primary thymic adenocarcinoma NOS was established. Recently, enteric-type adenocarcinoma was detected in a subset of adenocarcinoma NOS, but the current case was not of this type. The patient was alive without any sign of recurrence 30 months postoperatively. Conclusion: Our case report suggests that some adenocarcinomas NOS are not enteric and that this finding should be further evaluated.